Optimal Imaging Surveillance Schedules after Liver-Directed Therapy for Hepatocellular Carcinoma
- 1 January 2015
- journal article
- Published by Elsevier BV in Journal of Vascular and Interventional Radiology
- Vol. 26 (1), 69-73
- https://doi.org/10.1016/j.jvir.2014.09.013
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Recurrent Hepatocellular Carcinoma After Transcatheter Arterial ChemoembolizationJournal of Ultrasound in Medicine, 2011
- Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survivalJournal of Hepatology, 2010
- A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus RadioembolizationAmerican Journal of Transplantation, 2009
- Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2008
- Tumor Response after Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Comparison of Diffusion-weighted Functional MR Imaging with Anatomic MR ImagingJournal of Vascular and Interventional Radiology, 2008
- Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusionAlimentary Pharmacology & Therapeutics, 2007
- Hepatocellular Carcinoma Treated with Percutaneous Radio-frequency Ablation: Evaluation with Follow-up Multiphase Helical CTRadiology, 2001
- Surveillance Schedules for Medical ExaminationsManagement Science, 1974